Adial Pharmaceuticals, Inc (ADIL): Price and Financial Metrics
ADIL Price/Volume Stats
| Current price | $0.96 | 52-week high | $4.17 |
| Prev. close | $1.04 | 52-week low | $0.77 |
| Day low | $0.96 | Volume | 100,900 |
| Day high | $1.03 | Avg. volume | 69,645 |
| 50-day MA | $1.06 | Dividend yield | N/A |
| 200-day MA | $1.19 | Market Cap | 6.15M |
ADIL Stock Price Chart Interactive Chart >
Adial Pharmaceuticals, Inc (ADIL) Company Bio
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. The company was founded in 2010 and is based in Charlottesville, Virginia.
ADIL Price Returns
| 1-mo | -10.28% |
| 3-mo | -10.28% |
| 6-mo | -17.95% |
| 1-year | -26.61% |
| 3-year | -98.36% |
| 5-year | -98.10% |
| YTD | -4.95% |
| 2024 | -45.70% |
| 2023 | -65.40% |
| 2022 | -92.04% |
| 2021 | 58.82% |
| 2020 | -29.46% |
Loading social stream, please wait...